Neogen (NEOG) Investor Day 2026 summary
Event summary combining transcript, slides, and related documents.
Investor Day 2026 summary
15 Oct, 2026Strategic direction and market
FY26 focused on stabilization; FY27 shifts to acceleration and FY28 to expansion. Core growth improved from (2.9%) in Q4 FY25 to 4.3% in Q4 FY26, with positive core growth for four consecutive quarters.
FY26 revenue was $870M, comprising 77% Food Safety and 23% Animal Safety.
Animal and food safety addressable market exceeds $7B, with 4%-5% industry growth; priorities are to outgrow the market and expand profitability.
Foodborne illness costs the global economy $75B annually, and outbreaks are up 50% since 2015.
Commercial growth
Commercial model shifts from product-by-product selling to integrated point-of-processing workflows; global strategic account teams aim to standardize solutions and expand share of wallet.
Strategic accounts grew 6.2% YTD/Q1, with 8%+ targeted by year-end; new opportunities rose 32%, qualified pipeline reached $142M, and Q1 wins totaled $13M.
Animal Safety expansion targets Europe/EMEA, Latin America and Asia-Pacific through distribution and existing brands; ~15% of segment sales are international.
Point-of-processing testing is a $5B market projected to expand by $700M over five years, as $700M of testing spend shifts from centralized labs.
Digital commerce aims to improve routine-buyer self-service and focus field resources on accounts needing technical or enterprise support.
Innovation and product development
FY27 R&D investment is rising ~50%; the long-term target is ~5% of revenue by FY31.
Innovation goals include 5+ annual launches, $100M in new-product revenue by FY31, 15% targeted ROIC and a 10x vitality index; 18 projects advanced through development.
Petrifilm’s accessible market could expand >2.5x, including a $2B adjacent-applications opportunity by FY31; a next-generation reader targets 50% faster results in a $1.2B culture media market.
Petrifilm development and manufacturing are moving in-house; the automated facility has >3x current capacity, with validated equipment and a controlled multi-quarter transition planned from FY27.
Hinalea collaboration supports hyperspectral, non-destructive food-safety testing; Neogen Analytics links test results to workflows and predictive insights, with adopters using >1.5x consumables and the installed base generating >300M data points annually.
Latest events from Neogen
- Core growth and margin gains lifted FY27 guidance as the Petrifilm transition advanced.NEOG
Q1 2027 - All proposals passed with high approval, including director elections and plan amendments.NEOG
AGM 2026 - Correction increases ESPP share reserve to 6,000,000; Board recommends approval.NEOG
Proxy filing - Virtual annual meeting to vote on directors, compensation, auditor, and plan amendments.NEOG
Proxy filing - Improved growth, leadership changes, and enhanced ESG drive key proxy proposals for 2026.NEOG
Proxy filing - Q4 core growth accelerated, margins improved, and FY27 guidance signals continued momentum.NEOG
Q4 2026 - Integration progress and international growth position the business for margin expansion and recovery.NEOG
2024 Wells Fargo Healthcare Conference - Q2 FY26 delivered 2.9% core growth, margin expansion, and a raised FY26 outlook.NEOG
Q2 2026 - Q2 revenue hit $230M as integration advances, margin initiatives progress, and global growth accelerates.NEOG
Piper Sandler 36th Annual Healthcare Conference